Cilta-Cel Shows Superior Efficacy, Survival Over Ide-Cel, but Higher Toxicity in R/R MM | ASH Clinical News | American Society of Hematology

In patients with heavily pretreated R/R #MultipleMyeloma #MMsm, #ciltacel was found to be associated with better treatment responses compared with #idecel but had higher rates of toxicity, such as CRS: ashpublications.org/ashclinicaln...
#HemeSky #HemeOnc